Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 10.26
-0.28 (-2.66%)
May 28, 2026, 10:09 AM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 7.55 billion as of May 27, 2026. Its market cap has increased by 55.51% in one year.
Market Cap
7.55B
Enterprise Value
5.55B
Revenue
681.17M
Ranking
n/a
PE Ratio
107.09
Stock Price
10.26
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 7.55B, a decrease of -13.31%. That is a compound annual growth rate of -3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 7.55B | -13.67% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 10.87B |
| CARsgen Therapeutics Holdings | 10.35B |
| HBM Holdings | 10.30B |
| Alphamab Oncology | 9.54B |
| Shanghai Bao Pharmaceuticals | 8.13B |
| Shanghai Haohai Biological Technology | 8.06B |
| Lepu Biopharma | 7.96B |
| CK Life Sciences Int'l., (Holdings) | 6.73B |